E-script

National roll-out of e-prescriptions started in Germany

59.2m

EBITDA improvement (adjusted) in CHF

139m

Funds raised for refinancing and general corporate purposes in CHF

1/3

Percentage of women on the Board of Directors – target reached a year ahead of schedule

New logistics

Automation level increased in Heerlen to 70 per cent and capacity more than doubled to 27 million packages per year

Structure

medpex brand successfully integrated at the Heerlen location and the Eurapon brand discontinued

Sustainability

Second year of reporting focused on setting targets, optimised governance structure, carbon footprint, diversity and inclusion

+9.5%

Significant growth in Switzerland